Literature DB >> 34097292

More than tubular dysfunction: cystinosis and kidney outcomes.

Bahriye Atmis1, Aysun K Bayazit2, Derya Cevizli2, Deniz Kor3, Hatice Busra Fidan4, Atil Bisgin5,6,7, Sebile Kilavuz3, Ilker Unal8, Kivilcim Eren Erdogan9, Engin Melek2, Gulfiliz Gonlusen9, Ali Anarat2, Neslihan Onenli Mungan3.   

Abstract

BACKGROUND: Cystinosis is a lysosomal storage disease that affects many tissues. Its prognosis depends predominantly on kidney involvement. Cystinosis has three clinical forms: nephropathic infantile, nephropathic juvenile and non-nephropathic adult. Proximal tubular dysfunction is prominent in the infantile form, whereas a combination of glomerular and tubular alterations are observed in the juvenile form.
METHODS: Thirty-six children with nephropathic cystinosis were included in the study. Clinical features, molecular genetic diagnoses, and kidney outcomes of the patients were evaluated.
RESULTS: Twenty-one children (58.3%) were male. The median age at diagnosis was 18.5 months. Twenty-eight patients (77.8%) had infantile nephropathic cystinosis, while eight (22.2%) had juvenile nephropathic cystinosis. An acute rapid deterioration of the kidney function with proteinuria, hypoalbuminemia, and nephrotic syndrome, was observed in 37.5% of patients with the juvenile form. The mean estimated glomerular filtration rate (eGFR) was 82.31 ± 37.45 ml/min/1.73m2 at diagnosis and 63.10 ± 54.60 ml/min/1.73m2 at the last visit (p = 0.01). Six patients (16.6%) had kidney replacement therapy (KRT) at the last visit. The median age of patients with kidney failure was 122 months. Patients with a spot urine protein/creatinine ratio < 6 mg/mg at the time of diagnosis had better kidney outcomes (p = 0.01). The most common allele was c.451A>G (32.6%). The patients with the most common mutation tended to have higher mean eGFR and lower leukocyte cystine levels than patients with other mutations.
CONCLUSION: Glomerulonephritis may be a frequent finding in addition to the well-known tubular dysfunction in patients with cystinosis. Furthermore, our results highlight that the presence of severe proteinuria at the time of diagnosis is a relevant prognostic factor for kidney survival.
© 2021. Italian Society of Nephrology.

Entities:  

Keywords:  Children; Cystinosis; Glomerulonephritis; Kidney outcomes

Mesh:

Year:  2021        PMID: 34097292     DOI: 10.1007/s40620-021-01078-y

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  23 in total

Review 1.  Cystinosis.

Authors:  William A Gahl; Jess G Thoene; Jerry A Schneider
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

2.  Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.

Authors:  Albane Brodin-Sartorius; Marie-Josèphe Tête; Patrick Niaudet; Corinne Antignac; Geneviève Guest; Chris Ottolenghi; Marina Charbit; Dominique Moyse; Christophe Legendre; Philippe Lesavre; Pierre Cochat; Aude Servais
Journal:  Kidney Int       Date:  2011-09-07       Impact factor: 10.612

3.  Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.

Authors:  Marcella Greco; Milena Brugnara; Marco Zaffanello; Anna Taranta; Anna Pastore; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2010-08-29       Impact factor: 3.714

4.  Acute kidney injury in a patient with COVID-19: Answers.

Authors:  Tugba Tastemel Ozturk; Demet Baltu; Eda Didem Kurt Sukur; Yasemin Ozsurekci; Safak Gucer; Ozge Basaran; Bora Gulhan; Fatih Ozaltin; Ali Duzova; Rezan Topaloglu
Journal:  Pediatr Nephrol       Date:  2021-09-07       Impact factor: 3.651

5.  Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.

Authors:  Craig S Wong; Christopher B Pierce; Stephen R Cole; Bradley A Warady; Robert H K Mak; Nadine M Benador; Fredrick Kaskel; Susan L Furth; George J Schwartz
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 8.237

Review 6.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

7.  Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.

Authors:  Aude Servais; Vincent Morinière; Jean-Pierre Grünfeld; Laure-Hélène Noël; Jean-Michel Goujon; Bernadette Chadefaux-Vekemans; Corinne Antignac
Journal:  Clin J Am Soc Nephrol       Date:  2008-01       Impact factor: 8.237

8.  New equations to estimate GFR in children with CKD.

Authors:  George J Schwartz; Alvaro Muñoz; Michael F Schneider; Robert H Mak; Frederick Kaskel; Bradley A Warady; Susan L Furth
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

Review 9.  Cystinosis: practical tools for diagnosis and treatment.

Authors:  Martijn J Wilmer; Joost P Schoeber; Lambertus P van den Heuvel; Elena N Levtchenko
Journal:  Pediatr Nephrol       Date:  2010-08-24       Impact factor: 3.714

10.  Worldwide view of nephropathic cystinosis: results from a survey from 30 countries.

Authors:  Aurélia Bertholet-Thomas; Julien Berthiller; Velibor Tasic; Behrouz Kassai; Hasan Otukesh; Marcella Greco; Jochen Ehrich; Rejane de Paula Bernardes; Georges Deschênes; Sally-Ann Hulton; Michel Fischbach; Kenza Soulami; Bassam Saeed; Ehsan Valavi; Carlos Jose Cobenas; Bülent Hacihamdioglu; Gabrielle Weiler; Pierre Cochat; Justine Bacchetta
Journal:  BMC Nephrol       Date:  2017-07-03       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.